Guided by traditional meridian and acupoint theory, conducting standardized, large-sample, multicenter randomized controlled trials (RCTs) to evaluate the clinical efficacy of pattern differentiation and meridian-based acupoint selection for biliary colic across multiple levels can provide high-quality research evidence for developing evidence-based guidelines or optimal treatment protocols. This holds significant importance for enhancing the clinical efficacy of acupuncture in treating biliary colic and promoting its widespread clinical application. Therefore, this study will conduct a multicenter, large-sample randomized controlled trial comparing the clinical effects of acupuncture at Yanglingquan (GB34) versus drug therapy for acute cholecystitis biliary colic. It aims to investigate the clinical efficacy and safety of acupuncture treatment for acute cholecystitis biliary colic.
Meets diagnostic criteria for cholecystitis according to both Chinese and Western medicine;
Patients exhibiting clinical manifestations of biliary colic with a Visual Analogue Scale (VAS) score >4;
Aged 18 to 65 years;
Patients provide informed consent and voluntarily participate in this study.
Patients meeting criteria for emergency surgery;
Patients with psychiatric issues unable to cooperate with treatment;
Patients with severe complications such as suppurative cholecystitis, suppurative cholangitis, acute pancreatitis, gallbladder perforation, tumors, or severe infections;
Patients with other serious comorbidities including liver, brain, kidney, or cardiovascular diseases;
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead sponsor
Tianjin Medical University General Hospital
Collaborator
Tianjin Hospital of Integrated Traditional Chinese and Western Medicine
Collaborator